CABALETTA BIO, INC. (CABA) Social Stream
CABALETTA BIO INC (CABA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CABA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 6 | $22 | $20 | $21.25 | $13.88 | 53.1% |
| 2021-12-08 | 6 | $22 | $17 | $20.4 | $13.88 | 46.97% |
| 2021-12-14 | 6 | $22 | $15 | $19.4 | $13.88 | 39.77% |
| 2021-12-15 | 6 | $22 | $15 | $18.6 | $13.88 | 34.01% |
| 2022-05-16 | 6 | $22 | $11 | $16.4 | $13.88 | 18.16% |
| 2022-05-26 | 5 | $17 | $10 | $14 | $13.88 | 0.86% |
| 2022-08-15 | 5 | $17 | $10 | $13.2 | $13.88 | -4.9% |
| 2022-08-22 | 6 | $17 | $10 | $13.2 | $13.88 | -4.9% |
| 2022-08-30 | 6 | $17 | $3 | $10.8 | $13.88 | -22.19% |
| 2022-09-14 | 6 | $13 | $3 | $8.2 | $13.88 | -40.92% |
| 2022-11-14 | 6 | $12 | $3 | $8 | $13.88 | -42.36% |
| 2023-01-03 | 6 | $14 | $3 | $10 | $13.88 | -27.95% |
| 2023-01-27 | 6 | $16 | $10 | $12.6 | $13.88 | -9.22% |
| 2023-05-12 | 6 | $16 | $10 | $13.4 | $13.88 | -3.46% |
| 2023-08-11 | 5 | $34 | $14 | $20.25 | $13.88 | 45.89% |
| 2023-09-05 | 6 | $34 | $14 | $20.6 | $13.88 | 48.41% |
| 2023-09-18 | 6 | $39 | $16 | $25.6 | $13.88 | 84.44% |
| 2023-10-20 | 7 | $39 | $16 | $26.5 | $13.88 | 90.92% |
| 2023-10-25 | 8 | $40 | $16 | $28.428 | $13.88 | 104.81% |
| 2023-11-10 | 8 | $40 | $22 | $30.571 | $13.88 | 120.25% |
| 2023-11-15 | 8 | $50 | $22 | $32 | $13.88 | 130.55% |
The Trend in the Analyst Price Target
CABA's average price target has moved up $10 over the prior 44 months.
CABA reports an average of 46.37% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-07-18 | 7 | 34 | 10 | 16.833 | 13.98 | 20.41% |
| 2023-08-11 | 7 | 34 | 10 | 17.166 | 13.62 | 26.04% |
| 2023-08-11 | 7 | 34 | 12 | 18.600 | 13.62 | 36.56% |
| 2023-08-11 | 6 | 34 | 14 | 20.250 | 13.62 | 48.68% |
| 2023-10-20 | 8 | 39 | 16 | 26.500 | 13.42 | 97.47% |
CABA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
CABA's average broker recommendation rating improved by 0 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CABA has a lower variance in analysts' estimates than -1900.72% of all US stocks.
- In the context of all US stocks, CABALETTA BIO INC's average analyst price target is greater than 658.75% of them.
- In the context of Pharmaceutical Products stocks, CABALETTA BIO INC's upside potential (average analyst target price relative to current price) is greater than 560.54% of them.
- In terms of how CABALETTA BIO INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2139.87% of that group.
Stocks similar to CABALETTA BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IPHA, DTIL, and GNFT.
View All Top Stocks by Price Target
What is the outlook for CABA? Use POWR Ratings for clearer insight into price direction.